Keith A.A. Fox
1,277 works · 126,243 citations · h-index 148
Top works
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
- Fourth universal definition of myocardial infarction (2018)
- Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
- Third universal definition of myocardial infarction
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
- Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
- Third Universal Definition of Myocardial Infarction
- ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction
- Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
- A Validated Prediction Model for All Forms of Acute Coronary Syndrome
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen Activator
- Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial